ProfileGDS4718 / 215013_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 9% 12% 13% 14% 19% 19% 9% 12% 14% 14% 17% 16% 11% 17% 18% 18% 12% 15% 14% 21% 13% 18% 18% 19% 15% 15% 17% 33% 17% 16% 14% 24% 14% 8% 19% 17% 17% 16% 13% 8% 13% 12% 13% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.77489
GSM549102patient 115, normal, homogenized [OPG study]3.8581212
GSM549104patient 119, normal, homogenized [OPG study]3.8638713
GSM549108patient 138, normal, homogenized [OPG study]3.9501214
GSM549119patient 077, normal, homogenized [OPG study]4.1043519
GSM549133patient 032, cancer, homogenized [OPG study]4.0744219
GSM549139patient 042, cancer, homogenized [OPG study]3.735579
GSM549099patient 107, normal, homogenized [OPG study]3.8456412
GSM549109patient 139, normal, homogenized [OPG study]3.9610114
GSM549110patient 046, normal, homogenized [OPG study]3.9237314
GSM549114patient 063, normal, homogenized [OPG study]3.9965717
GSM549122patient 082, normal, homogenized [OPG study]3.9965716
GSM549134patient 033, cancer, homogenized [OPG study]3.8115911
GSM549136patient 036, cancer, homogenized [OPG study]3.9811317
GSM549140patient 044, cancer, homogenized [OPG study]4.0231318
GSM549111patient 047, normal, homogenized [OPG study]4.0281318
GSM549113patient 057, normal, homogenized [OPG study]3.8295612
GSM549132patient 031, cancer, homogenized [OPG study]3.9542315
GSM549137patient 038, cancer, homogenized [OPG study]3.9325214
GSM549142patient 047, cancer, homogenized [OPG study]4.2909621
GSM549100patient 110, normal, homogenized [OPG study]3.9029213
GSM549107patient 135, normal, homogenized [OPG study]4.0326218
GSM549115patient 068, normal, homogenized [OPG study]4.021418
GSM549116patient 072, normal, homogenized [OPG study]4.1077419
GSM549120patient 078, normal, homogenized [OPG study]3.9612115
GSM549131patient 030, cancer, homogenized [OPG study]3.9128615
GSM549118patient 074, normal, homogenized [OPG study]4.0258317
GSM549129patient 027, cancer, homogenized [OPG study]4.6904433
GSM549123patient 088, normal, homogenized [OPG study]4.0497817
GSM549124patient 006, cancer, homogenized [OPG study]4.0484316
GSM549126patient 015, cancer, homogenized [OPG study]3.9104514
GSM549128patient 025, cancer, homogenized [OPG study]4.2537724
GSM549103patient 117, normal, homogenized [OPG study]3.9384814
GSM549117patient 073, normal, homogenized [OPG study]3.716598
GSM549138patient 041, cancer, homogenized [OPG study]4.0980619
GSM549141patient 045, cancer, homogenized [OPG study]3.9673917
GSM549130patient 028, cancer, homogenized [OPG study]4.0330417
GSM549101patient 111, normal, homogenized [OPG study]3.9904916
GSM549105patient 128, normal, homogenized [OPG study]3.9070313
GSM549106patient 134, normal, homogenized [OPG study]3.670728
GSM549112patient 048, normal, homogenized [OPG study]3.8786113
GSM549125patient 011, cancer, homogenized [OPG study]3.8472212
GSM549127patient 024, cancer, homogenized [OPG study]3.8597713
GSM549135patient 035, cancer, homogenized [OPG study]4.1988623